LIFS News 0.1400 Life Stem Genetics Inc. (LIFS)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Life Stem Genetics Inc. (LIFS) 0.1400 $LIFS

Life Stem Genetics Strengthens its Medical Advisory Board with the Appointments of Three Doctors
PR Newswire - Tue Apr 08, 1:18PM CDT
Life Stem Genetics, Inc. (LIFS), an emerging company in the advancement of adult stem cell therapies, today announced the appointments of Dr. Roberto Fernandez Vina, Dr. Ranbir Singh Gill, and Dr. Praveen Gill to its Medical Advisory Board.

Life Stem Genetics hires Dr Vino Padayachee as director and board chair
M2 - Fri Mar 21, 5:32AM CDT
Cell therapies company Life Stem Genetics (Other OTC:LIFS) revealed on Thursday that it has appointed Dr Vino Padayachee as director and chairman of its board of directors.

Life Stem Genetics appoints Dr. Vino Padayachee as Director and Chairman of the Board of Directors
PR Newswire - Thu Mar 20, 8:30AM CDT
Life Stem Genetics, Inc. (LIFS), an emerging innovator in the advancement of Adult Stem Cell therapies, today announced the appointment of Dr. Vino Padayachee, a well-known family physician/anesthetist, as Director and Chairman of the Board of Directors of the company. Dr. Padayachee has been actively involved in the Saskatchewan Medical Association as a member of the Representative Assembly, the Board of Directors, and the executive. He served as Chief of Staff of St. Joseph's Hospital in Estevan, Saskatchewan, from 1998 to 2009, as Chief of Staff of South East Health District from 1999 to 2004, and as Chief of Staff of Sun Country Health Region from 2004 to 2008. He was the first Clinical Chair for the Health Quality Council Chronic Disease Management Collaborative from 2005 to 2007. Dr. Padayachee served as President of the Saskatchewan Medical Association in 2006-2007 and as CEO of the Saskatchewan Medical Association from 2011 to February 2014.

Life Stem Genetics Inc partners with American CryoStem for patient's adipose tissue sample storage
M2 - Mon Nov 25, 4:26AM CST
Healthcare company Life Stem Genetics Inc (OTC BB:LIFS) reported on Friday the launch of a strategic collaborative agreement for the long term storage of their patient's adipose tissue sample.

Life Stem Genetics Announces Collaborative Agreement with American CryoStem
Business Wire - Fri Nov 22, 7:30AM CST
Life Stem Genetics, Inc. (OTCBB:LIFS) announced today a strategic collaborative agreement with American CryoStem Corporation, (OTCBB:CRYO). CRYO is a leading developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries.

Life Stem Genetics Announces the Closing of Its Previously Announced $1 Million Private Placement
Business Wire - Tue Nov 19, 7:30AM CST
Life Stem Genetics, Inc. (OTCBB:LIFS) (the "Company" is pleased to announce yesterday's closing of its previously announced private placement. The financing is for $1.0 million (the "Private Placement" of 1,000,000 units (each, a "Unit" at a price of $1 per Unit.

Life Stem Genetics Inc names James Vanden Bosch as chief medical stem cell specialist
M2 - Mon Nov 18, 3:01AM CST
Healthcare company Life Stem Genetics Inc (OTCBB:LIFS) reported on Friday the addition of James Vanden Bosch, BHA, as its chief medical stem cell specialist.

Life Stem Genetics Announces James Vanden Bosch as Chief Medical Stem Cell Specialist
Business Wire - Fri Nov 15, 8:37AM CST
Life Stem Genetics, Inc. (LIFS.OTCBB) (the "Company" announces that its Regenerative Specialist, James Vanden Bosch,BHA, has been given the title and responsibility of Chief Medical Stem Cell Specialist at Life Stem Genetics. Mr. Vanden Bosch has been in healthcare for more than a decade and has performed thousands of stem cell treatments on patients. Mr. Vanden Bosch is an accomplished speaker and premier expert in regenerative and stem cell treatments and is an author and publisher of articles to major Medical News Journals on subjects of Orthopedics, Autoimmune, and Neurological conditions.

Life Stem Genetics Announces LOI with Stem Cell Therapy Clinic in Dhaka, Bangladesh
Business Wire - Wed Nov 13, 7:30AM CST
Life Stem Genetics, Inc. (OTCBB:LIFS) (the"Company" announces the signing of a Letter of Intent ("LOI" between Life Stem Genetics, Inc. and Dr. Iqram Rahman ("IR" in Dhaka, Bangladesh.

Detailed Coverage on NVLX, PGLO, LIFS and DROP
ACCESSWIRE - Wed Nov 13, 1:02AM CST
Nuvilex, Inc. (OTC:NVLX), Pan Global Corp. (OTCGLO), Life Stem Genetics Inc. (OTC:LIFS) and Fuse Science, Inc. (OTCROP) have been added to our coverage list.

Life Stem Genetics Announces LOI with a Chain of Health Clinics across Canada
Business Wire - Thu Nov 07, 7:30AM CST
Life Stem Genetics, Inc. (OTCBB:LIFS) announces the signing of a Letter of Intent ("LOI" between Life Stem Genetics, Inc. and a soon to be disclosed health and wellness chain in Canada ("Company". The announcement of the organization is set to take place in approximately 10 days upon signing of the definitive agreement.

Exclusive Coverage on LIFS, VELT, FVRG and NVGC
ACCESSWIRE - Thu Nov 07, 5:35AM CST
Life Stem Genetics Inc. (OTC: LIFS), Velti Plc (NASDAQ: VELT), ForeverGreen Worldwide Corp. (OTC: FVRG) and Nevada Gold Corp (OTC: NVGC) have been added to our watch list.

Life Stem Genetics Inc names Dr. Rostamkalaee to Executive Advisory Board
M2 - Tue Nov 05, 4:02AM CST
Healthcare company Life Stem Genetics Inc (OTC BB:LIFS) revealed on Monday the addition of Dr. Shirin Rostamkalaee to its newly expanded Executive Advisory Board.

Life Stem Genetics Adds Dr. Rostamkalaee to Enhance Its Executive Advisory Board
Business Wire - Mon Nov 04, 7:30AM CST
Life Stem Genetics, Inc. (OTCBB: LIFS), an emerging innovator in the advancement of Adult Stem Cell therapy, today announced that it has added Dr. Shirin Rostamkalaee, an expert on wound healing, bone grafting, and reconstructive surgery (broad areas with immense applications for Adult Stem Cell ("ASC" therapies) to its newly expanded Executive Advisory Board. The addition of Dr. Rostamkalaee follows the recent appointments of Matthew Sullivan, COO of global health products company Asana International, and Shahab Bakhtyar, an independent medical business consultant with extensive global experience, to the company's Executive Advisory Board.

Life Stem Genetics Strengthens Its Executive Advisory Board by Adding MBAs Matthew Sullivan and Shahab Bakhtyar
Business Wire - Mon Oct 28, 8:00AM CDT
Life Stem Genetics Inc., an emerging innovator in the advancement of Adult Stem Cell therapy, is pleased to announce that Matthew Sullivan, COO of global heath products company Asana International, and Shahab Bakhtyar, an independent medical business consultant with global experience, have joined Life Stem's Executive Advisory Board.

Life Stem Genetics is Pleased to Announce That It Has Completed the First $500,000 Private Placement of the Recently Announced $1mm Private Placement
Business Wire - Tue Oct 22, 8:30AM CDT
Life Stem Genetics (OTCBB:LIFS) is pleased to announce that it has completed and received the first $500,000 of the recently announced $1mm Private Placement. Our company is very happy to receive the first half of our recent private placement and hopes to close the additional $500,000 in the coming weeks.

Life Stem Genetics Has New Stock Symbol and New Financing Commitment
Business Wire - Sat Oct 19, 11:47AM CDT
Life Stem Genetics Inc. (the "Company", an emerging innovator in the advancement of Adult Stem Cell therapy announces that the Company's new stock symbol, LIFS, is now active.

Life Stem Genetics has new stock symbol and new financing commitment
Filing Services Canada - Sat Oct 19, 11:47AM CDT
Life Stem Genetics Inc. (LIFS - OTCBB), (the "Company", an emerging innovator in the advancement of Adult Stem Cell therapy announces that the Company's new stock symbol, LIFS, is now active.

Solace Therapeutics Adds New Member to Board of Directors
Business Wire - Tue Sep 17, 9:00AM CDT
Solace Therapeutics, a venture capital funded medical technology company focusing on treating stress urinary incontinence (SUI), announced today that Stacy Enxing Seng has joined the Board of Directors. She serves on the board alongside Ryan Drant, General Partner with New Enterprise Associates (NEA); Ali Behbahani MD, Principal at NEA; John McDonough, CEO at T2 Biosystems; and Kevin G. Connors, founding partner of Spray Venture Partners.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEPAS AURA Signals a Sharper Design Bet for Future Cars

Updated Category News Views 145

A porcelain-smooth concept car is not a balance sheet, but it can tell you where a young automotive brand intends to spend its attention. LEPAS unveiled AURA in October at its first Global Elegant Lifestyle Week, presenting it as the brand's first global concept car and a fresh expression of its Leopard Aesthetics design language. That matters because AURA is plainly not...

Continue Reading
Valley Family Health Breach Notice Raises Hard Questions

Updated Category News Views 41

Seven months is a long time for sensitive patient data to sit inside an unresolved security story. Valley Family Health Care, Inc. says it suffered a network disruption on or about March 13, 2026, investigated with outside cybersecurity specialists, and ultimately determined that an unauthorized actor accessed and acquired certain files. The formal notification process...

Continue Reading
Chemours Legal Succession Gets a Long Transition Runway

Updated Category News Views 46

A corporate-law handoff rarely sets pulses racing, but this one deserves a proper look. Chemours is replacing its long-serving general counsel while keeping the departing executive in the building for four additional months. That is not flashy, and thank goodness for that. In a global chemicals company, legal leadership touches regulation, compliance, governance,...

Continue Reading
Peptide Labels Cannot Substitute for Clinical Care

Updated Category News Views 91

A Label Is Not a Care Plan Those three little words, research use only, carry far more weight than a flashy product page would have people believe. The HelloNation article featuring wellness expert Andres Giraldo makes a plain but necessary distinction: a research-use-only, or RUO, label does not turn a peptide into prescribed treatment, and it sure does not establish...

Continue Reading
Visual Cipher Bench Exposes AI Agents' Hidden Rule Gap

Updated Category News Views 95

Forty little black-and-white puzzles just threw a bucket of cold water on the autonomous-agent sales pitch. Einsia AI’s Navers Lab says its new Visual Cipher Bench found that the best result among eight frontier models was only 26.7%, with no tested configuration clearing 30%. That is not a minor blemish. It is a reminder that a model can sound clever, use tools, and...

Continue Reading
SAGA's Radar Assays Tighten the Trapper North Case

Updated Category News Views 125

Rock that keeps showing up where the model says it should is the sort of boring news a junior miner desperately needs. SAGA Metals has put out fresh assay results from Radar’s Trapper North area, and the useful part is not merely a loud grade in one hole. It is the apparent persistence of thick titanium-vanadium-iron oxide mineralization across tighter-spaced drilling....

Continue Reading
Excel Treatment Center Adds ART Trauma Therapy Option

Updated Category News Views 117

Trauma rarely arrives at an addiction program wearing a name tag. Excel Treatment Center in Dover, New Jersey, is responding to that uncomfortable reality by adding Accelerated Resolution Therapy® (ART) to the individual, group, and family therapy already available to its clients. The center says its therapists have completed ART training, and the approach is now part of...

Continue Reading
BKV Energy's $400,000 Loyalty Bet Has a Real Point Behind It

Updated Category News Views 73

Retail power customers rarely send thank-you notes; they switch plans, complain about bills, or quietly vanish. That is why BKV Energy putting more than $400,000 into its third annual ElectroShare payout deserves a harder look than the usual feel-good loyalty announcement. A Retention Expense With Some Teeth The payout has climbed quickly: roughly $113,000 in the first...

Continue Reading
MERSCO’s Holiday Push Tests Backyard Play Demand in 2026

Updated Category News Views 22

A trampoline sale is not exactly a macroeconomic bellwether, but it does expose a useful little corner of holiday spending: parents buying big, awkward, discretionary stuff that has to earn its space in the yard. MERSCO is joining Amazon’s Black Friday and Cyber Monday window from November 19 through November 30, 2026, with discounts reaching 38% on selected products....

Continue Reading
Elijah Craig Uses AI Toasts to Sell a Warmer Pour

Updated Category News Views 38

A Speech Prompt With a Bourbon Label Few things expose holiday nerves faster than a raised glass and a room waiting for somebody to say something memorable. Elijah Craig has decided that awkward little moment is marketing territory, rolling out its Digital Perfect Pour, Perfect Toast Generator for mobile and desktop users ahead of the holiday season. The tool asks for a...

Continue Reading
/section>

Top 5 Most Recently Viewed Articles

Unveiling Groundbreaking Research on Cenobamate at AES 2025

Updated Category News Views 163

Exciting New Developments in Epilepsy Treatment SK Life Science, Inc., a leading player in central nervous system (CNS) disorder treatments and a subsidiary of SK Biopharmaceuticals Co., Ltd., is ready to unveil ten posters featuring new research on cenobamate at the upcoming American Epilepsy Society (AES) Annual Meeting. This prestigious event will take place in...

Continue Reading
Teck Resources Unveils Strong First Quarter Earnings for 2025

Updated Category News Views 384

Teck Resources Limited Reports Impressive First Quarter Results Teck Resources Limited (NYSE: TECK, TSX: TECK.A, TSX: TECK.B) has announced its unaudited financial results for the first quarter of 2025, showcasing significant improvements over previous years. This marks a period of enhanced profitability driven by favorable market conditions. Financial Performance...

Continue Reading
Understanding Your Rights in the Symbotic Class Action

Updated Category News Views 155

Taking Action: Your Rights as an Investor in Symbotic Inc. Investors of Symbotic Inc. should be aware of a class action lawsuit initiated on their behalf. The law firm Kirby McInerney LLP is advocating for those who acquired Symbotic securities during the noted class period. This comes as a crucial reminder for shareholders to stay informed and consider their rights in...

Continue Reading
Scott Kelly Joins Worthington Steel Board, Boosting Strategy

Updated Category News Views 431

Scott Kelly Named to Worthington Steel Board Worthington Steel, Inc. (NYSE:WS), a prominent player in the metals processing industry, has officially welcomed Scott Kelly to its board of directors. This strategic appointment comes at a significant time as the company navigates its market challenges, including a recent 10% dip in stock price. Despite this, Worthington...

Continue Reading
Treasury Securities Agreements: A New Era for Primary Dealers

Updated Category News Views 232

Understanding the Latest Developments in Treasury Securities In a significant move to fortify the issuance and market making in Treasury securities, the Government Debt Management, on behalf of the Treasury, has signed crucial agreements with primary dealers. This initiative aims to ensure the Treasury’s uninterrupted access to financing while enhancing price formation...

Continue Reading